Загрузка...
A conceptualization of the utility of subjective cognitive decline in clinical trials of preclinical Alzheimer’s disease
INTRODUCTION: This commentary outlines a conceptual model for subjective cognitive decline (SCD) in relation to Alzheimer’s disease (AD) biomarkers in the preclinical stages of disease, and a framework for effectively utilizing SCD in secondary prevention clinical trials. OBJECTIVE: Mounting evidenc...
Сохранить в:
| Опубликовано в: : | J Mol Neurosci |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5241130/ https://ncbi.nlm.nih.gov/pubmed/27514526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12031-016-0810-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|